Abstract
The most common metastatic sites of differentiated thyroid cancer (DTC) are the lung and bone after lymph nodes. A newly defined type of occult DTC is consistent with metastatic disease without an identified primary malignancy in the thyroid gland after total resection. We present a patient with multiple lung metastases of occult DTC showing mild 18F-fluorodeoxyglucose (FDG) uptake and intense radioiodine uptake without a primary lesion in the thyroid gland.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sampson E, Brierley JD, Le LW, Rotstein L, Tsang RW. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer. 2007;110:1451–6.
Kalra R, Pawar R, Hasija S, Chandna A, Sankla M, Malhotra C. Frontal bone metastasis from an occult follicular thyroid carcinoma: diagnosed by FNAC. J Cytol. 2017;34:59–61.
Liu H, Lv L, Yang K. Occult thyroid carcinoma: a rare case report and review of literature. Int J Clin Exp Pathol. 2014;7:5210–4.
Borsò E, Boni G, Mazzarri S, Cocciaro A, Gambacciani C, Traino AC, et al. Disseminated bone metastases from occult thyroid cancer effectively treated with debulking surgery and a single dosimetry-guided administration of radioiodine. Rev Esp Med Nucl Imagen Mol. 2015;34:111–5.
Xu B, Scognamiglio T, Cohen PR, Prasad ML, Hasanovic A, Michael Tuttle R, et al. Metastatic thyroid carcinoma without identifiable primary tumor within the thyroid gland: a retrospective study of a rare phenomenon. Hum Pathol. 2017;65:133–9.
Kaseda K, Watanabe K, Sakamaki H, Kazama A. Solitary pulmonary metastasis from occult papillary thyroid carcinoma. Thorac Cancer. 2016;7:261–3.
Qutbi M, Shafeie B, Amoui M, Tabeie F, Azizmohammadi Z, Mahmoud-Pashazadeh A, et al. Evaluation of prognostic factors associated with differentiated thyroid carcinoma with pulmonary metastasis. Clin Nucl Med. 2016;41:917–21.
Kim M, Kim WG, Park S, Kwon H, Jeon MJ, Lee JJ, et al. Initial size of metastatic lesions is best prognostic factor in patients with metastatic differentiated thyroid carcinoma confined to the lung. Thyroid. 2017;27:49–58.
Song HJ, Qiu ZL, Shen CT, Wei WJ, Luo QY. Pulmonary metastases in differentiated thyroid cancer: efficacy of radioiodine therapy and prognostic factors. Eur J Endocrinol. 2015;173:399–408.
Wang R, Zhang Y, Tan J, Zhang G, Zhang R, Zheng W, et al. Analysis of radioiodine therapy and prognostic factors of differentiated thyroid cancer patients with pulmonary metastasis: an 8-year retrospective study. Medicine (Baltimore). 2017;96:e6809. https://doi.org/10.1097/MD.0000000000006809.
Biko J, Reiners C, Kreissl MC, Verburg FA, Demidchik Y, Drozd V. Favourable course of disease after incomplete remission on (131)I therapy in children with pulmonary metastases of papillary thyroid carcinoma: 10 years follow-up. Eur J Nucl Med Mol Imaging. 2011;38:651–5.
Basu S, Parghane RV. Designing and developing PET-based precision model in thyroid carcinoma: the potential avenues for a personalized clinical care. PET Clin. 2017;12:27–37.
Giraudet AL, Taïeb D. PET imaging for thyroid cancers: current status and future directions. Ann Endocrinol. 2017;78:38–42.
Vrachimis A, Burg MC, Wenning C, Allkemper T, Weckesser M, Schäfers M. [(18)F]FDG PET/CT outperforms [(18)F]FDG PET/MRI in differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2016;43:212–20.
Kim MS, Sim YS, Lee SY, Jeon DG. Occult thyroid carcinoma detected by FDG-PET scan in elderly osteosarcoma patients: report of two cases. Ann Nucl Med. 2007;21:529–32.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Çermik, T.F., Ergül, N. (2019). A Patient Presented with Extensive Lung Metastases of Papillary Thyroid Carcinoma Without Any Primary Focus Detected on Total Thyroidectomy. In: Özülker, T., Adaş, M., Günay, S. (eds) Thyroid and Parathyroid Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-78476-2_30
Download citation
DOI: https://doi.org/10.1007/978-3-319-78476-2_30
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-78475-5
Online ISBN: 978-3-319-78476-2
eBook Packages: MedicineMedicine (R0)